表紙
市場調查報告書
商品編碼
1034323

血管閉合設備的全球市場 (∼2026年):各類型 (被動式合攏器、主動式合攏器、外部止血設備)、接取 (股骨、橈骨)、治療 (介入性心臟學、介入性無線電生物學/血管外科)、地區

Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) - Global Forecast to 2026

出版日期: | 出版商: MarketsandMarkets | 英文 177 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血管閉合設備的市場規模在預測期間內預計以7.0%的年複合成長率發展,從2021年的9億美元,成長到2026年13億美元的規模。

血管閉合設備的批准數量多,心血管疾病的高盛行率,肥胖增加,對大口徑的血管閉合設備的進入經營者的關注度高漲,老年人口增加,對介入性無線電生物學手術有利的償付方案,對手術中患者的有效出血管理的關注度高漲等要素促進該市場的成長。同時,有先進技術的專家的必要性,血管閉合設備伴隨的風險,嚴格的法律規範等,可能給予市場成長一定的課題。

本報告提供全球血管閉合設備的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,類型、接取、治療、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19的影響

第6章 血管閉合設備市場:各類型

  • 被動式合攏器
    • 膠原蛋白插頭
    • 密封膠或凝膠為基礎的設備
    • 壓迫支援設備
  • 主動式合攏器
    • 縫合為基礎的設備
    • 夾為基礎的設備
  • 外部止血設備

第7章 血管閉合設備市場:各接取

  • 股骨接取
  • 橈骨接取

第8章 血管閉合設備市場:各治療

  • 介入性心臟學
  • 介入性無線電生物學/血管外科

第9章 血管閉合設備市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 競爭情形

  • 概要
  • 主要企業的策略
  • 收益佔有率分析
  • 市場佔有率分析
  • 企業評估象限
  • 企業評估象限:SME/Start-Ups
  • 競爭模式

第11章 企業簡介

  • 主要企業
    • TERUMO CORPORATION
    • ABBOTT LABORATORIES
    • CARDINAL HEALTH
    • CARDIVA MEDICAL, INC.
    • MEDTRONIC PLC
    • MORRIS INNOVATIVE, INC.
    • TELEFLEX INCORPORATED
    • MERIT MEDICAL SYSTEMS, INC.
    • VASORUM LTD.
    • TZ MEDICAL, INC.
  • 其他企業
    • VIVASURE MEDICAL LTD.
    • TRICOL BIOMEDICAL
    • SCION BIOMEDICAL
    • ADVANCED VASCULAR DYNAMICS
    • MARINE POLYMER TECHNOLOGIES, INC.
    • TRANSLUMINAL TECHNOLOGIES
    • REX MEDICAL
    • MERIL LIFE SCIENCES PVT. LTD.
    • MEDAS USA
    • VYGON COMPANY

第12章 附錄

目錄
Product Code: MD 5243

The global vascular closure devices market is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period. The growth in this market can be attributed to a large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries. Emerging markets providing growth opportunities for market players and growth in the number of hospitals & surgical centers are expected to offer strong growth opportunities for players in the market. In contrast, the need for highly skilled professionals, risks associated with vascular closure devices, and stringent regulatory framework may challenge market growth to a certain extent. The vascular closure devices market is segmented based on type, access, procedure, and region.

"Passive approximators segment is expected to dominate the market during the forecast period."

Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.

"Radial access segment to dominate the market during the forecast period."

Based on access, the vascular closure devices market is segmented into radial access and femoral access. The femoral access segment commanded the largest share of the vascular closure devices market. . The large share of this segment can be attributed to the advantages of femoral access, such as better patient comfort, cost-effectiveness, and reduced hospitalization time.

"Interventional cardiology segment to dominate the market during the forecast period."

Based on procedure, the vascular closure devices market is segmented into interventional cardiology procedures and interventional radiology/vascular surgery. Interventional cardiology for the largest share of the vascular closure devices market. The large share is attributed to the diagnosis and treatment of numerous cardiovascular disorders due to advancements in angioplasty and cardiac stenting and the growing prevalence of cardiac disorders globally.

"North America will dominate the market during the forecast period."

The global vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 52%, Tier 2: 30% and Tier 3: 18%
  • By Designation - C-level: 45%, D-level: 30%, and Others: 25%
  • By Region - North America: 36%, Europe: 24%, Asia Pacific: 29%, and Rest of World: 11%

List of Companies Profiled in the Report

  • Terumo Corporation (Japan)
  • Abbott (US)
  • Cardinal Health (US)
  • Cardiva Medical, Inc. (US)
  • Medtronic Plc (Ireland)
  • Morris Innovative, Inc. (US)
  • Teleflex Incorporated (US)
  • Merit Medical Systems, Inc. (US)
  • Vasorum Ltd. (Ireland)
  • TZ Medical, Inc. (US)
  • Vivasure Medical Ltd. (Ireland)
  • Tricol Biomedical (US)
  • Scion Biomedical (US)
  • Advanced Vascular Dynamics (US)
  • Marine Polymer Technologies, Inc. (US)
  • Transluminal Technologies (US)
  • Rex Medical (US)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Medas USA (US)
  • Vygon Company (France)

Research Coverage:

This report provides a detailed picture of the global vascular closure devices market. It aims at estimating the size and future growth potential of the market across different segments, such as type, access, procedure and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vascular closure devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on vascular closure devices offered by the top 20 players in the vascular closure devices market. The report analyses the vascular closure devices market by type, access, procedure and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various vascular closure devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular closure devices market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the vascular closure devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • FIGURE 1 VASCULAR CLOSURE DEVICES MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
  • 2.2 SECONDARY DATA
    • 2.2.1 SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
    • 2.3.2 KEY INDUSTRY INSIGHTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.4 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.4.1 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.6 MARKET SHARE ANALYSIS
  • 2.7 ASSUMPTIONS FOR THE STUDY
    • 2.7.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.8 LIMITATIONS
  • 2.9 RISK ASSESSMENT
  • 2.10 COVID-19 ECONOMIC ASSESSMENT
  • 2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 11 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW
    • FIGURE 15 LARGE NUMBER OF APPROVALS FOR VASCULAR CLOSURE DEVICES TO DRIVE MARKET GROWTH
  • 4.2 VASCULAR CLOSURE DEVICES MARKET, BY TYPE (2021-2026)
    • FIGURE 16 PASSIVE APPROXIMATORS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.3 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE AND COUNTRY (2020)
    • FIGURE 17 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN VASCULAR CLOSURE DEVICES MARKET IN 2020
  • 4.4 VASCULAR CLOSURE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 19 VASCULAR CLOSURE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing approvals of vascular closure devices
    • TABLE 1 APPROVALS OF VASCULAR CLOSURE DEVICES
      • 5.2.1.2 High prevalence of cardiovascular diseases
      • 5.2.1.3 Increasing prevalence of obesity
      • 5.2.1.4 Increasing focus of market players on large-bore vascular closure devices
      • 5.2.1.5 Growing geriatric population
      • 5.2.1.6 Favorable reimbursement scenario for interventional radiology procedures
    • TABLE 2 REIMBURSEMENTS FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US
      • 5.2.1.7 Rising focus on effective blood loss management in patients during surgeries
      • 5.2.1.8 Increasing investments, funds, and grants for research on vascular devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing preference for interventional procedures using radial artery access
      • 5.2.2.2 High cost of vascular closure devices
      • 5.2.2.3 Product recalls and failures
    • TABLE 3 RECENT RECALLS OF VASCULAR CLOSURE DEVICES
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets providing growth opportunities for market players
      • 5.2.3.2 Growth in the number of hospitals & surgical centers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Need for highly skilled professionals
      • 5.2.4.2 Risks associated with vascular closure devices
      • 5.2.4.3 Stringent regulatory frameworks
  • 5.3 COVID-19 IMPACT ON THE VASCULAR CLOSURE DEVICES MARKET

6 VASCULAR CLOSURE DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 4 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 5 VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
  • 6.2 PASSIVE APPROXIMATORS
    • TABLE 6 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 7 PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 8 PASSIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 9 PASSIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.2.1 COLLAGEN PLUGS
      • 6.2.1.1 Growing number of approvals for collagen-based vascular closure devices to drive market growth during the forecast period
    • TABLE 10 COLLAGEN PLUGS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 11 COLLAGEN PLUGS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.2.2 SEALANT OR GEL-BASED DEVICES
      • 6.2.2.1 Sealant or gel-based devices to register the highest growth rate during the forecast period
    • TABLE 12 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 13 SEALANT OR GEL-BASED DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.2.3 COMPRESSION ASSIST DEVICES
      • 6.2.3.1 Compression assist devices do not leave behind any foreign body in the tissue artery-a major advantage of these devices
    • TABLE 14 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 15 COMPRESSION ASSIST DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 6.3 ACTIVE APPROXIMATORS
    • TABLE 16 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 17 ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 18 ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 19 ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.3.1 SUTURE-BASED DEVICES
      • 6.3.1.1 Increasing applications of suture-based devices to favor market growth
    • TABLE 20 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 21 SUTURE-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.3.2 CLIP-BASED DEVICES
      • 6.3.2.1 Growing innovation in the field of clip-based devices to aid market growth
    • TABLE 22 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 23 CLIP-BASED ACTIVE APPROXIMATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 6.4 EXTERNAL HEMOSTATIC DEVICES
    • 6.4.1 RISING ADOPTION OF MINIMALLY INVASIVE THERAPEUTIC PROCEDURES TO DRIVE MARKET GROWTH
    • TABLE 24 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 25 EXTERNAL HEMOSTATIC DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)

7 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS

  • 7.1 INTRODUCTION
    • TABLE 26 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 27 VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
  • 7.2 FEMORAL ACCESS
    • 7.2.1 ADVANTAGES ASSOCIATED WITH FEMORAL ACCESS, SUCH AS GREATER COMFORT LEVEL FOR PATIENTS AND REDUCED COST OF HOSPITALIZATION, TO DRIVE MARKET GROWTH
    • TABLE 28 FEMORAL ACCESS: RESEARCH STUDIES
    • TABLE 29 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 30 FEMORAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 7.3 RADIAL ACCESS
    • 7.3.1 TRANSRADIAL APPROACH REDUCES VASCULAR COMPLICATIONS COMPARED TO THE FEMORAL ARTERY ACCESS APPROACH-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 31 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 32 RADIAL ACCESS VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)

8 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE

  • 8.1 INTRODUCTION
    • TABLE 33 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 34 VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
  • 8.2 INTERVENTIONAL CARDIOLOGY
    • 8.2.1 ASSOCIATED BENEFITS OF INTERVENTIONAL CARDIOLOGY PROCEDURES, SUCH AS REDUCED SCARRING AND LESS PAIN, TO DRIVE MARKET GROWTH
    • TABLE 35 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 36 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, BY REGION, 2021-2026 (USD MILLION)
  • 8.3 INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY
    • 8.3.1 GROWTH IN THE PREVALENCE OF PAD IS INCREASING THE DEMAND FOR ENDOVASCULAR INTERVENTIONAL PROCEDURES
    • TABLE 37 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 38 VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY PROCEDURES, BY REGION, 2021-2026 (USD MILLION)

9 VASCULAR CLOSURE DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 39 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 40 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
    • TABLE 41 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 42 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 43 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 44 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 46 NORTH AMERICA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 47 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 48 NORTH AMERICA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 49 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 50 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 52 NORTH AMERICA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American vascular closure devices market
    • TABLE 53 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020
    • TABLE 54 US: KEY MACROINDICATORS
    • TABLE 55 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 56 US: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 57 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 58 US: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 59 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 60 US: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 61 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 62 US: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 63 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 64 US: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising prevalence of target diseases to drive market growth
    • TABLE 65 CANADA: KEY MACROINDICATORS
    • TABLE 66 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 67 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 68 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 69 CANADA: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 70 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 71 CANADA: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 72 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 73 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 74 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 75 CANADA: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 76 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION, BY COUNTRY, 2018
    • TABLE 77 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
    • TABLE 78 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 79 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 80 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 81 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 82 EUROPE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 83 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 84 EUROPE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 85 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 86 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 87 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 88 EUROPE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
    • 9.3.1 E-3
      • 9.3.1.1 Increase in number of radial procedures to boost the market demand
    • TABLE 89 GERMANY: KEY MACROINDICATORS
    • TABLE 90 UK: KEY MACROINDICATORS
    • TABLE 91 FRANCE: KEY MACROINDICATORS
    • TABLE 92 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 93 E-3: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 94 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 95 E-3: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 96 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 97 E-3: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 98 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 99 E-3: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 100 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 101 E-3: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
    • 9.3.2 REST OF EUROPE
    • TABLE 102 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 103 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 104 ROE: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 105 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 106 ROE: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 107 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 108 ROE: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 109 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 110 ROE: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 111 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 112 ROE: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 INCREASING HEALTH EXPENDITURE TO DRIVE MARKET GROWTH IN APAC
    • FIGURE 21 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET SNAPSHOT
    • TABLE 113 CHINA: KEY MACROINDICATORS
    • TABLE 114 JAPAN: KEY MACROINDICATORS
    • TABLE 115 INDIA: KEY INDICATORS
    • TABLE 116 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • 9.5.1 GOVERNMENT INITIATIVES TO PROMOTE HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH
    • TABLE 126 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 127 ROW: VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 128 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 129 ROW: PASSIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 130 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2017-2020 (USD MILLION)
    • TABLE 131 ROW: ACTIVE APPROXIMATORS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 132 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2017-2020 (USD MILLION)
    • TABLE 133 ROW: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2021-2026 (USD MILLION)
    • TABLE 134 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2017-2020 (USD MILLION)
    • TABLE 135 ROW: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2021-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 136 OVERVIEW OF STRATEGIES ADOPTED BY KEY VASCULAR CLOSURE DEVICES MARKET PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 22 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE VASCULAR CLOSURE DEVICES MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 23 VASCULAR CLOSURE DEVICES MARKET SHARE ANALYSIS, 2020
    • TABLE 137 VASCULAR CLOSURE DEVICES MARKET: DEGREE OF COMPETITION (2020)
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 24 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 25 VASCULAR CLOSURE DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 138 PRODUCT LAUNCHES & APPROVALS
    • 10.7.2 DEALS
    • TABLE 139 DEALS
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 140 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 TERUMO CORPORATION
    • TABLE 141 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 26 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 142 EXCHANGE RATES (USED FOR THE CONVERSION OF YEN TO USD)
    • 11.1.2 ABBOTT LABORATORIES
    • TABLE 143 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 11.1.3 CARDINAL HEALTH
    • TABLE 144 CARDINAL HEALTH: BUSINESS OVERVIEW
    • FIGURE 28 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
    • 11.1.4 CARDIVA MEDICAL, INC.
    • TABLE 145 CARDIVA MEDICAL, INC.: BUSINESS OVERVIEW
    • 11.1.5 MEDTRONIC PLC
    • TABLE 146 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
    • 11.1.6 MORRIS INNOVATIVE, INC.
    • TABLE 147 MORRIS INNOVATIVE, INC.: BUSINESS OVERVIEW
    • 11.1.7 TELEFLEX INCORPORATED
    • TABLE 148 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 30 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
    • 11.1.8 MERIT MEDICAL SYSTEMS, INC.
    • TABLE 149 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
    • FIGURE 31 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.9 VASORUM LTD.
    • TABLE 150 VASORUM LTD.: BUSINESS OVERVIEW
    • 11.1.10 TZ MEDICAL, INC.
    • TABLE 151 TZ MEDICAL INC.: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 VIVASURE MEDICAL LTD.
    • 11.2.2 TRICOL BIOMEDICAL
    • 11.2.3 SCION BIOMEDICAL
    • 11.2.4 ADVANCED VASCULAR DYNAMICS
    • 11.2.5 MARINE POLYMER TECHNOLOGIES, INC.
    • 11.2.6 TRANSLUMINAL TECHNOLOGIES
    • 11.2.7 REX MEDICAL
    • 11.2.8 MERIL LIFE SCIENCES PVT. LTD.
    • 11.2.9 MEDAS USA
    • 11.2.10 VYGON COMPANY
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS